Previously infected vaccinees broadly neutralize SARS-CoV-2 variants

We compared the serum neutralizing antibody titers before and after two doses of the BNT162b2 COVID-19 vaccine in ten individuals who recovered from SARS-CoV-2 infection prior to vaccination to 20 individuals with no history of infection, against clinical isolates of B.1.1.7, B.1.351, P.1, and the o...

Descripción completa

Detalles Bibliográficos
Autores principales: Leier, Hans C., Bates, Timothy A., Lyski, Zoe L., McBride, Savannah K., Lee, David X., Coulter, Felicity J., Goodman, James R., Lu, Zhengchun, Curlin, Marcel E., Messer, William B., Tafesse, Fikadu G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095208/
https://www.ncbi.nlm.nih.gov/pubmed/33948601
http://dx.doi.org/10.1101/2021.04.25.21256049

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095208/
https://www.ncbi.nlm.nih.gov/pubmed/33948601
http://dx.doi.org/10.1101/2021.04.25.21256049

Ejemplares similares